City Of Hope National Medical Center (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
146
Publications
2106
Citations
114290
i10-index
721
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Atezolizumab and Nab-Paclitaxel in Advanced Triple... | 2018 | 4347 |
Palbociclib and Letrozole in Advanced Breast Cance... | 2016 | 3014 |
Everolimus in Postmenopausal Hormone-Receptor–Posi... | 2011 | 2862 |
Trastuzumab Deruxtecan in Previously Treated HER2-... | 2022 | 2759 |
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Po... | 2019 | 2635 |
Talazoparib in Patients with Advanced Breast Cance... | 2018 | 2182 |
3rd ESO–ESMO International Consensus Guidelines fo... | 2016 | 2037 |
Pembrolizumab plus chemotherapy versus placebo plu... | 2020 | 1819 |
Sacituzumab Govitecan in Metastatic Triple-Negativ... | 2021 | 1729 |
Leukocyte Complexity Predicts Breast Cancer Surviv... | 2011 | 1699 |
Hope S. Rugo is a researcher with 2106 publications and 114290 citations. They are affiliated with City Of Hope National Medical Center. Their research focuses on . With an h-index of 146, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Hope S. Rugo and 300M+ other papers.
Citations per publication by year